V
Velocity Clinical Research | Huntington Park, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
BI456906
RGT001-075
Petrelintide
Parent organization
This site is a part of Velocity Clinical Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 3 total trials
The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or...
Active, not recruiting
Overweight
Obesity
Other: Placebo
Drug: Petrelintide
This is a phase 2, 36-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the safety, tolerability, weight loss...
Active, not recruiting
Obesity or Overweight
Drug: Placebo Comparator
Drug: RGT001-075
Trial sponsors
R
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems